stablishment of a diagnostic model for clinical stage Ⅰ non-small cell lung cancer: A study based on clinical imaging features combined with folate receptor-positive circulating tumor cells tests
10.7507/1007-4848.202101072
- VernacularTitle:临床Ⅰ期非小细胞肺癌诊断模型构建：基于临床影像学特征联合叶酸受体阳性循环肿瘤细胞检测的研究
- Author:
Dezhi KONG
1
;
Ao LIU
1
;
Jian CUI
1
;
Xiaoliang LENG
1
;
Yang WO
1
;
Yanting DONG
1
;
Wenjie JIAO
1
Author Information
1. Department of Thoracic Surgery, Affiliated Hospital of Qingdao University, Qingdao, 266071, Shandong, P.R.China
- Publication Type:Journal Article
- Keywords:
Non-small cell lung cancer;
early diagnosis;
nomogram;
folate receptor;
circulating tumor cell
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2021;28(10):1192-1201
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the correlation between folate receptor-positive circulating tumor cells (FR+CTC) and the benign or malignant lesions of the lung, and to establish a malignant prediction model for pulmonary neoplasm based on clinical data, imaging and FR+CTC tests. Methods A retrospective analysis was done on 1 277 patients admitted to the Affiliated Hospital of Qingdao University from September 2018 to December 2019, including 518 males and 759 females, with a median age of 57 (29-85) years. They underwent CTC examination of peripheral blood and had pathological results of pulmonary nodules and lung tumors. The patients were randomly divided into a trial group and a validation group. Univariate and multivariate analyses were performed on the data of the two groups. Then the nomogram prediction model was established and verified internally and externally. Receiver operating characteristic (ROC) curve was used to test the differentiation of the model and calibration curve was used to test the consistency of the model. Results Totally 925 patients suffered non-small cell lung cancer and 113 patients had benign diseases in the trial group; 219 patients suffered non-small cell lung cancer and 20 patients had benign diseases in the verification group. The FR+CTC in the peripheral blood of non-small cell lung cancer patients was higher than that found in the lungs of the patients who were in favorite conditions (P<0.001). Multivariate analysis showed that age≥60 years, female, FR+CTC value>8.7 FU/3 mL, positive pleural indenlation sign, nodule diameter, positive burr sign, consolidation/tumor ratio<1 were independent risk factors for benign and malignant lung tumors with a lesion diameter of ≤4 cm. Thereby, the nomogram prediction model was established. The area under the ROC curve (AUC) of the trial group was 0.918, the sensitivity was 86.36%, and the specificity was 83.19%. The AUC value of the verification group was 0.903, the sensitivity of the model was 79.45%, and the specificity was 90.00%, indicating nomogram model discrimination was efficient. The calibration curve also showed that the nomogram model calibration worked well. Conclusion FR+CTC in the peripheral blood of non-small cell lung cancer patients is higher than that found in the lungs of the patients who carry benign pulmonary diseases. The diagnostic model of clinical stage Ⅰ non-small cell lung cancer established in this study owns good accuracy and can provide a basis for clinical diagnosis.
